99mtc-1-thio-d-glucose
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 15, 2020 (NCT04288518)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04288518 | Phase 1/Phase 2 (Phase 2) | Feb 15, 2020 | Russian Academy of Medical Sciences, Uppsala University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Uppsala University | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1